Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Driven by strong sales in the cancer medicines, the revenues for Roche reached SwF30 billion* in the first 9 months of 2006,

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      PharmaTimes.Roche says strong sales bring it into sixth place in global league. Pharma Times: [2 pages], 17 Oct 2006. Available from: URL: http://www.pharmatimes.com

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Driven by strong sales in the cancer medicines, the revenues for Roche reached SwF30 billion* in the first 9 months of 2006,. Pharmacoecon. Outcomes News 515, 14 (2006). https://doi.org/10.2165/00151234-200605150-00050

    Download citation

    Keywords

    • Public Health
    • Health Outcome
    • Bevacizumab
    • Trastuzumab
    • Market Share